Helsinn Healthcare S.A. v. Hospira Inc.
1:15-cv-00264
Overview
Parties
Defendant
Plaintiff
Helsinn Healthcare S.A. NPE (Individual / Inventor)
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 21 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7947724
Liquid pharmaceutical formulations of palonosetron
|
Filed: 2005-07-21
Issued: 2011-05-24
|
Expired (Term Ended)
Expires: 2025-07-21
|
|
|
US7947725
Liquid pharmaceutical formulations of palonosetron
|
Filed: 2006-03-24
Issued: 2011-05-24
|
Expired (Term Ended)
Expires: 2026-03-24
|
|
|
US7960424
Liquid pharmaceutical formulations of palonosetron
|
Filed: 2006-03-24
Issued: 2011-06-14
|
Expired (Term Ended)
Expires: 2026-03-24
|
|
|
US8598219
Liquid pharmaceutical formulations of palonosetron
|
Filed: 2013-05-23
Issued: 2013-12-03
|
Active (6.5 yrs remaining)
Expires: 2033-05-23
|
|
|
US8729094
Liquid pharmaceutical formulations of palonosetron
|
Filed: 2013-05-24
Issued: 2014-05-20
|
Active (6.5 yrs remaining)
Expires: 2033-05-24
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
14
Dispositive
1
Granted
1
Denied
0
Pending / Review
13
Motions by Category
Key Dispositive Motions & Rulings